Carestream Molecular Imaging Expands Global Presence

Carestream Health, Inc.Carestream Molecular Imaging, a division of Carestream Health, Inc., is expanding its international presence with new dealer partnerships and a growing worldwide customer base. The company announced several new European dealer relationships and a host of recent customer wins.

New dealer partners in Europe and the Middle East include BioNova Cientifica, S.l. in Spain, Biosense S.R.L. in Italy, Csertex KFT in Hungary, and TransOrient Trading Co. in Palestine.

"Delivering our proven molecular imaging solutions to research institutions globally, in collaboration with best-of-breed partners, is a logical extension of our international strategy," said John DelliSanti, President of Carestream Molecular Imaging. "The demand for a cost effective and translatable molecular imaging solution is growing rapidly. We intend to significantly increase our international efforts and expect to achieve continued growth and expansion into new markets around the globe."

The company's European dealer network is dedicated to increasing the presence of the company's optical molecular imaging systems and fluorescent imaging agents to prominent pharmaceutical companies and research institutions. Partners such as Advanced Molecular Vision Ltd., AMV Germany, BioTech a.s., Csertex Ltd., Metis Biyoteknoloji and Metis-Turkey have been instrumental in the company's recent customer successes in the following European institutions:

  • Baxter AG
  • Charles University of Prague, Ege University School of Medicine, Tulay Aktas Oncology Hospital
  • Humboldt Universität Berlin
  • Hungarian Academy of Sciences' Institute of Experimental Medicine
  • Imperial College London's Kennedy Institute of Rheumatology
  • Institute for Molecular Pathology IMP Istanbul University
  • Department of Molecular Biology Istanbul University Faculty of Medicine
  • University of Debrecen's Department of Physiology
  • University of Dundee's Division of Molecular Physiology
  • University of Edinburgh's MRC Centre for Inflammation Research

Carestream Molecular Imaging is showcasing its portfolio of in vivo digital molecular imaging systems and imaging agents at the 2008 World Molecular Imaging Conference.

Carestream Health, an independent company, has licensed the KODAK brand for use with its own brands across its portfolio of leading-edge molecular imaging, medical imaging and healthcare IT products.

Related news articles:

About Carestream Molecular Imaging
Carestream Molecular Imaging group, a division of Carestream Health, Inc., develops and markets high performance digital imaging systems, imaging agents, film and accessories under the KODAK brand for the life science research and drug discovery/development market segments. For more information, visit www.carestreamhealth.com/molecular-imaging.html.

About Carestream Health, Inc.
Carestream Health, Inc. is a leading provider of dental and medical imaging systems and healthcare IT solutions; molecular imaging solutions for the life science research and drug discovery/development market segments; and x-ray film and digital x-ray products for the non-destructive testing market. The company emerged in 2007 when Onex Corporation (TSX: OCX) of Toronto, Canada, purchased Eastman Kodak Company’s Health Group. For more information about Carestream Health, contact your Carestream Health representative or visit www.carestreamhealth.com.

KODAK is a trademark of Kodak used under license.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...